RFQ 75D30123Q76157 Production Distribution and Storage of NAx10 Materials.pdf

REQUEST FOR QUOTATIONS

(THIS IS NOT AN ORDER)

THIS RFQ IS X IS NOT A SMALL BUSINESS SET-ASIDE.

PAGE OF PAGES

1 27

1. REQUEST NO.

75D301-23-Q-76157

2. DATE ISSUED

04/21/2023

3. REQUISITION/PURCHASE REQUEST NO.

00HCUGDH-2023-74992

4. CERT. FOR NAT. DEF.

UNDER BDSA REG. 2

AND/OR DMS REG. 1

RATING

5a. ISSUED BY

Centers for Disease Control and Prevention (CDC)

Office of Acquisition Services (OAS)

2900 Woodcock Blvd

Atlanta, GA 30341

6. DELIVERY BY (Date)

09/22/2023

5b. FOR INFORMATION CALL (No collect calls) x

NAME TELEPHONE NUMBER

AREA CODE NUMBER

William O’Bryan 678 475-4755

8. TO: 9. DESTINATION

a. NAME b. COMPANY a. NAME OF CONSIGNEE

c. STREET ADDRESS b. STREET ADDRESS

c. CITY

d. CITY e. STATE f. ZIP CODE d. STATE e. ZIP CODE

10. PLEASE FURNISH QUOTATIONS TO

THE ISSUING OFFICE IN BLOCK 5a ON OR BEFORE CLOSE OF BUSINESS (Date)

05/14/2023

IMPORTANT: This is a request for information, and quotations furnished are not offers. If you are unable to quote, please so indicate on this form and return it. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or services.

Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this Request for Quotations must be completed by the quoter.

11. SCHEDULE (Include applicable Federal, State and local taxes)

ITEM NO.

(a)

SUPPLIES/SERVICES

(b)

QUANTITY

(c)

UNIT

(d)

UNIT PRICE

(e)

AMOUNT

(f)

Submit questions via email using attached template to William O’Bryan at rvq0@cdc.gov by 5:00 PM EDT on 04/28/2023.

Submit quotes via email to rvq0@cdc.gov by

5:00 PM EDT on 05/14/2023.

12. DISCOUNT FOR PROMPT PAYMENT

a. 10 CALENDAR DAYS

b. 20 CALENDAR DAYS

c. 30 CALENDAR DAYS

d. CALENDAR DAYS

NUMBER PERCENTAGE

NOTE: Additional provisions and representations x are are not attached.

13. NAME AND ADDRESS OF QUOTER 14. SIGNATURE OF PERSON AUTHORIZED TO

SIGN QUOTATION

15. DATE OF

QUOTATION

a. NAME OF QUOTER

b. STREET ADDRESS 16. SIGNER

a. NAME (Type or print) b. TELEPHONE

c. COUNTY AREA CODE

d. CITY e. STATE f. ZIP CODE c. TITLE (Type or print) NUMBER

AUTHORIZED FOR LOCAL REPRODUCTION STANDARD FORM 18 (REV. 6-95)

Previous edition not usable Prescribed by GSA FAR (48 CFR) 53.215-1(a)

7. DELIVERY

FOB

DESTINATION

OTHER

(See Schedule) mailto:rvq0@cdc.gov mailto:rvq0@cdc.gov

75D301-23-Q-76157

Section B - Line Items

ITEM DESCRIPTION QTY/UNIT UNIT PRICE EXTENDED PRICE

0001 Tasks 1-4: OPNA Metabolite Reference Materials

Delivery of (4) NAx10 calibration packs, (8) NAx10 internal standard packs, (8) NAx10U quality control packs, and (8) NAx10S quality control packs to CDC

Period of Performance: 5/22/2023 - 9/22/2023

**Nonseverable**

1 Job

0002 Task 5: OPNA Metabolite Reference Materials

Reservation and Storage of NAx10 materials for the lifetime of the contract

Period of Performance: 5/22/2023 - 5/21/2028

**Severable Services **

1 Job

Total Contract Quote (CLIN 0001 - 0002) $__________________

Pricing Table for Sale to Other LRN-C Laboratories – shall be completed by contractor

Pack Number of Vials per Pack Price per Pack

NAx10 Calibration Pack (NAx10-CP)

(12 vials each of the following:

calibration solutions (S1-S8)

NAx10 Internal Standard Pack (NAx10-ISP) 17

NAx10 Urine Quality Control Pack (NAx10-QCP)

(30 vials each of the following: quality control solutions (QL, QM, and QH))

NAx10 Serum Quality Control Pack (NAx10-QCP)

(30 vials each of the following: quality control solutions (QL, QM, and QH))

SECTION C – Performance Work Statement

Title: Production, Distribution, and Storage of NAx10 Materials

C.1 Background:

The Emergency Response Branch (ERB) of the Centers for Disease Control and Prevention/National Center for

Environmental Health/Division of Laboratory Sciences (CDC/NCEH/DLS) is responsible for improving the detection, diagnosis, treatment, and prevention of disease from exposure to synthetic and naturally occurring chemical threat agents in order to protect the public health in the event of a chemical emergency. To achieve this end goal, ERB must develop effective and valid clinical methods for measuring chemicals and their metabolites in biological fluids, assure the quality of these methods, transfer these methods to other public health organizations including members of the Laboratory Response Network for Chemical Threats (LRN-C), and apply these methods to incidents of suspected exposure.

ERB has been tasked with providing ongoing laboratory improvement support for the LRN-C. To fulfill this request, ERB has identified a need for the development of reference materials for proficiency testing, calibration, and quality control programs for the detection of biomarkers for exposure chemical threat agents.

C.2 Project Objective:

The objectives of this requirement are to obtain spiked samples in biological matrices necessary for accomplishing

ERB’s mission to maintain testing capabilities for toxic chemicals of interest in order to support the measurement of exposures to chemical threat agents. The proposed work will include a variety of tasks that will require planning, producing, and distributing reference materials in support of ERB’s chemical emergency preparedness and response goals.

C.3 Description of work:

The primary purpose of this requirement is to obtain reference materials from an ISO 17034 provider to support response activities for toxic chemicals of interest. The contractor shall produce a sizeable, homogeneous lot of a material that meets the criteria listed below. Most quality testing for this material shall be performed by the contractor; however a small amount, detailed below, shall be shipped to a designated laboratory for verification.

The contractor shall make this materials available for purchase by LRN-C laboratories that participate in proficiency testing for this method at the same price-per-unit attributed to each item in the pricing table. This objective supports

ERB’s mission and requires a flexible and multi-faceted approach including the key tasks provided in the Task List below.

These NAx10 samples shall be made available for purchase, at rates provided in section B, by LRN-C laboratories that participate in proficiency testing for this method at the same price attributed to each task listed below. This objective supports ERB’s mission and requires a flexible and multi-faceted approach including the key tasks provided in the Task List below.

C.4 Description of Method

Method Material

Name

Sample

Matrix

Spiked Analyte(s) Expected

Participants

Organophosphorous

Nerve Agent

Metabolites in Urine and Serum

NAx10 Human Urine and Human

Serum

GBA, GDA, GFA, VXA, rVXA

(spiking compounds to be provided by CDC)

Task

List

Deliverable Description Date of

Delivery

1 Preparation of the Organophosphorous Nerve Agent Metabolite Calibration Pack (NAx10-CP) for the

Organophosphorous Nerve Agent Metabolites in Urine and Serum method as described in the Description of

Method table according to ISO 17034 standards. Each NAx10-CP will contain twelve vials each of the following:

calibration solutions (S1-S8). Each calibration standard must contain at least 1.2 mL of water containing each of the analytes at the concentrations described below. Each sample must be stored in a 2 mL flame-sealed wide bore ampoule (or equivalent container) and stored at -80°C until shipment. Each container must be labeled to provide the standard name, lot number, matrix, and standard concentrations. Calibration and internal standard solutions should contain concentration information on the label, but quality control solutions (Tasks 3 and 4) must NOT contain concentration information on the label.

Standard

Name Solvent

GBA

Concentration

(ng/mL)

GDA

Concentration

(ng/mL)

GFA

Concentration

(ng/mL) rVXA

Concentration

(ng/mL)

VXA

Concentration

(ng/mL)

NAx10-S1 Water 25 25 25 25 25

NAx10-S2 Water 62.5 62.5 62.5 62.5 62.5

NAx10-S3 Water 125 125 125 125 125

NAx10-S4 Water 250 250 250 250 250

NAx10-S5 Water 625 625 625 625 625

NAx10-S6 Water 1250 1250 1250 1250 1250

NAx10-S7 Water 2500 2500 2500 2500 2500

NAx10-S8 Water 5000 5000 5000 5000 5000

The final batch shall contain at least 57 CPs, or 684 calibration standard solutions per standard level in 2 mL flame-sealed wide bore ampoules (or equivalent container). CDC requires 4 CPs. The remaining CPs (53) shall be made available for purchase by LRN-C laboratories that participate in proficiency testing for this method. It is anticipated that approximately 44 CPs will be purchased by LRN-C laboratories within the first year of the contract, and approximately 9 CPs will remain in reserve beyond the first year as described in Task 5.

Quality/Evaluation Criteria: The accuracy and homogeneity of the batch shall be established by liquid chromatography – mass spectrometry (LC-MS) or other agreed-upon analytical method by testing no less than 3% of the calibration vials in the batch. During production, prior to aliquot from bulk production into ampoules, the vendor shall send CDC (1) ampoule/vial of each calibration solution to confirm the concentration of each solution.

The vendor and CDC will mutually agree upon a timeframe for approval. The final batch must meet the following criteria for all analytes. A summary of the accuracy and homogeneity data shall be sent to CDC for review.

Standard Name Accuracy %RSD

NAx10-S1 ±20% ±20%

NAx10-S2 ±15% ±15%

NAx10-S3 – S8 ±10% ±10%

Documentation: Certificate of analysis and safety data sheet documentation shall be completed for this material and a hardcopy must be provided to all recipients with the shipment of materials. The certificate of analysis shall include the following information regarding the analyte composition, target analyte concentration (except for quality control solutions), analyte purity, solvent composition, sample volume, storage conditions, handling instructions, and retest/retire date, which shall be assigned as the final date of the period of performance on this award.

Within

120 Days of Award

2 Preparation of the Organophosphorous Nerve Agent Metabolite Internal Standard Pack (NAx10-ISP) for the

Organophosphorous Nerve Agent Metabolites in Urine and Serum method as described in the Description of

Method table according to ISO 17034 standards. Each NAx10-ISP shall contain seventeen vials of the internal standard solution (IS). Each internal standard shall contain at least 1.2 mL of water containing each of the isotopically labeled analytes at the concentrations described below. Each sample must be stored in a 2 mL flame-sealed wide bore ampoule (or equivalent container) and stored at -80°C until shipment. Each container shall be labeled to provide the standard name, lot number, matrix, and standard concentrations. Calibration and internal standard solutions shall contain concentration information on the label, but quality control solutions (Tasks 3 and 4) must NOT contain concentration information on the label.

Standard

Name Solvent

Labeled GBA

Concentration

(ng/mL)

Labeled GDA

Concentration

(ng/mL)

Labeled GFA

Concentration

(ng/mL)

Labeled rVXA

Concentration

(ng/mL)

Labeled VXA

Concentration

(ng/mL)

NAx10-IS Water 3750 3750 3750 3750 3750

The final batch shall contain at least 61 ISPs, or 1037 internal standard solutions in 2 mL flame-sealed wide bore ampoules (or equivalent container). CDC requires 8 ISPs. The remaining ISPs (53) shall be made available for purchase by LRN-C laboratories that participate in proficiency testing for this method. It is anticipated that approximately 44 ISPs will be purchased by LRN-C laboratories within the first year of the contract, and approximately 9 ISPs will remain in reserve beyond the first year as described in Task 5.

Quality/Evaluation Criteria: The accuracy and homogeneity of the batch shall be established by liquid chromatography – mass spectrometry (LC-MS) or other agreed-upon analytical method by testing no less than 2% of the vials in the batch. During production, prior to aliquot from bulk production into ampoules, the vendor shall send CDC (1) ampoule/vial of the internal standard solution to confirm the concentration. The vendor and CDC will mutually agree upon a timeframe for approval. The final batch shall meet the following criteria for all analytes. A summary of the accuracy and homogeneity data shall be sent to CDC for review.

Standard Name Native Analyte

Concentration (ng/mL)

%RSD

NAx10-IS Less than NAx10-S1 ±15%

Documentation: Certificate of analysis and safety data sheet documentation shall be completed for this material and a hardcopy shall be provided to all recipients with the shipment of materials. The certificate of analysis shall include the following information regarding the analyte composition, target analyte concentration (except for quality control solutions), analyte purity, solvent composition, sample volume, storage conditions, handling instructions, and retest/retire date, which shall be assigned as the final date of the period of performance on this award.

Within

3 Preparation of the Organophosphorous Nerve Agent Metabolite in Serum Quality Control Pack (NAx10S-QCP) for the Organophosphorous Nerve Agent Metabolites in Serum method as described in the Description of Method table according to ISO 17034 standards. Each NAx10S-QCP shall contain thirty vials each of the following: quality control solutions (QCL, QCM, and QCH). Each calibration standard shall contain at least 0.25 mL of human serum containing each of the analytes at the concentrations described below. Each sample shall be stored in a 1.2 mL clear, screw-top cryovial (or equivalent container) and stored at -80°C until shipment. Each container shall be labeled to provide the standard name, lot number, matrix, and standard concentrations. Calibration and internal standard solutions shall contain concentration information on the label, but quality control solutions (Tasks 3 and 4) must NOT contain concentration information on the label.

Material Name Solvent

GBA

Concentration

(ng/mL)

GDA

Concentration

(ng/mL)

GFA

Concentration

(ng/mL) rVXA

Concentration

(ng/mL)

VXA

Concentration

(ng/mL)

NAx10S-QCL Human

Serum 7 7 7 7 7

NAx10S-QCM Human

Serum 35 35 35 35 35

NAx10S-QCH Human

Serum 120 120 120 120 120

The final batch shall contain at least 114 Serum QCPs, or 3,420 serum quality control solutions per level in 1.2 mL clear, screw-top cryovials (or equivalent container). CDC requires 8 Serum QCPs. The remaining Serum QCPs

(106) shall be made available for purchase by LRN-C laboratories that participate in proficiency testing for this method. It is anticipated that approximately 88 Serum QCPs will be purchased by LRN-C laboratories within the first year of the contract, and approximately 18 Serum QCPs will remain in reserve beyond the first year as described in Task 5.

Quality/Evaluation Criteria: The accuracy and homogeneity of the batch shall be established by liquid chromatography – mass spectrometry (LC-MS) or other agreed-upon analytical method by testing no less than 1% of the quality control vials in the batch. During production, prior to aliquot from bulk production into ampoules, the vendor shall send CDC (1) ampoule/vial of each quality control solution to confirm the concentration of each solution. The vendor and CDC will mutually agree upon a timeframe for approval. The final batch must meet the following criteria for all analytes. A summary of the accuracy and homogeneity data shall be sent to CDC for review.

NAx10S-QCL ±20% ±20%

NAx10S-QCM ±10% ±10%

NAx10S-QCH ±10% ±10%

Documentation: Certificate of analysis and safety data sheet documentation shall be completed for this material and a hardcopy must be provided to all recipients with the shipment of materials. The certificate of analysis shall include the following information regarding the analyte composition, target analyte concentration (except for quality control solutions), analyte purity, solvent composition, sample volume, storage conditions, handling instructions, and retest/retire date, which shall be assigned as the final date of the period of performance on this award.

Within

4 Preparation of the Organophosphorous Nerve Agent Metabolite in Urine Quality Control Pack (NAx10U-QCP) for the Organophosphorous Nerve Agent Metabolites in Urine method as described in the Description of Method table according to ISO 17034 standards. Each NAx10S-QCP shall contain thirty vials each of the following: quality control solutions (QCL, QCM, and QCH). Each calibration standard shall contain at least 0.6 mL of human urine containing each of the analytes at the concentrations described below. Each sample shall be stored in a 1.2 mL clear, screw-top cryovial (or equivalent container) and stored at -80°C until shipment. Each container shall be labeled to provide the standard name, lot number, matrix, and standard concentrations. Calibration and internal standard solutions shall contain concentration information on the label, but quality control solutions (Tasks 3 and 4) must

NOT contain concentration information on the label.

Material Name Solvent

GBA

Concentration

(ng/mL)

GDA

Concentration

(ng/mL)

GFA

Concentration

(ng/mL) rVXA

Concentration

(ng/mL)

VXA

Concentration

(ng/mL)

NAx10U-QCL Human

Urine 7 7 7 7 7

NAx10U-QCM Human

Urine 35 35 35 35 35

NAx10U-QCH Human

Urine 120 120 120 120 120

The final batch shall contain at least 114 Urine QCPs, or 3,420 calibration standard solutions per standard level in

1.2 mL clear, screw-top cryovials (or equivalent container). CDC requires 8 Urine QCPs. The remaining Urine

QCPs (106) shall be made available for purchase by LRN-C laboratories that participate in proficiency testing for this method. It is anticipated that approximately 88 Urine QCPs will be purchased by LRN-C laboratories within the first year of the contract, and approximately 18 Urine QCPs will remain in reserve beyond the first year as described in Task 5.

Quality/Evaluation Criteria: The accuracy and homogeneity of the batch shall be established by liquid chromatography – mass spectrometry (LC-MS) or other agreed-upon analytical method by testing no less than 1% of the quality control vials in the batch. During production, prior to aliquot from bulk production into ampoules, the vendor shall send CDC (1) ampoule/vial of each quality control solution to confirm the concentration of each solution. The vendor and CDC will mutually agree upon a timeframe for approval. The final batch must meet the following criteria for all analytes. A summary of the accuracy and homogeneity data shall be sent to CDC for review.

NAx10U-QCL ±20% ±20%

NAx10U-QCM ±10% ±10%

NAx10U-QCH ±10% ±10%

Documentation: Certificate of analysis and safety data sheet documentation shall be completed for this material and a hardcopy must be provided to all recipients with the shipment of materials. The certificate of analysis shall include the following information regarding the analyte composition, target analyte concentration (except for quality control solutions), analyte purity, solvent composition, sample volume, storage conditions, handling instructions, and retest/retire date, which shall be assigned as the final date of the period of performance on this award.

Within

5 Reservation of NAx10 Materials: The contractor shall make this materials available for purchase by LRN-C laboratories that participate in proficiency testing for this method at the same price-per-pack attributed to each item in the pricing table.

Storage of NAx10 Materials: Any materials not purchased within the first year of the contract shall be stored by the contractor and made exclusively available for purchase by CDC-approved laboratories for the remainder of the contract.

Within

C.5 Performance Matrix:

PERFORMANCE

OBJECTIVE

STANDARD PERFORMANCE

THRESHOLD

ACCEPTABLE

QUALITY LEVELS

(AQLs)

METHOD OF

SURVEILLANCE

Task 1: 4 Calibration Packs

(NAx10-CPs) delivered to

CDC

Additional CPs should be sent to participating laboratories upon payment from participating laboratory

Accuracy for each analyte in each calibration standard must fall within: ±20% for

S1, ±15% for S2, and

±10% for S3 through S8.

The %RSD across the batch for each analyte in each calibration standard must fall within: ±20% for

S1, ±15% for S2, and

±10% for S3 through S8.

No deviations from the standard allowed

Government inspection and acceptance

Task 2: 8 Calibration Packs

(NAx10-ISPs) delivered to

CDC

Additional ISPs should be laboratories upon payment from participating laboratory

Concentration of each native analyte must be less than the concentration present in NAx10-S1.

the internal standard must fall within: ±15%.

No deviations from the standard allowed

Task 3: 8 Serum Quality

Control Packs (NAx10S-

QCPs) delivered to CDC

Additional S-QCPs should be laboratories upon payment from participating laboratory

Accuracy for each analyte in each quality control must fall within: ±20% for

QL and ±10% for QM and

QH.

each quality control must fall within: ±20% for QL, and ±10% for QM and QH.

No deviations from the standard allowed

Task 4: 8 Urine Quality

Control Packs (NAx10U-

QCPs) delivered to CDC

Additional U-QCPs should be sent to participating laboratories upon payment from participating laboratory

Accuracy for each analyte in each quality control must fall within: ±20% for

QL and ±10% for QM and

QH.

each quality control must fall within: ±20% for QL, and ±10% for QM and QH.

No deviations from the standard allowed

Task 5: Remaining NAx10 materials should be made exclusively available for

100% of remaining NAx10 materials should be reserved and stored

No deviations from the standard allowed Government inspection purchase by participating laboratories at the ascribed for the lifetime of the contract

AND

Remaining NAx10 materials should be stored at -80 °C for the lifetime of the contract appropriately for the lifetime of the contract

C.6 Government-Furnished Information:

ERB will provide the contractor with a list of participating laboratories for the Organophosphorous Nerve Agent

Metabolites in Urine and Serum method along with contact information for each participating laboratory, if needed.

CDC will also provide ordering information to each of the participating laboratories once the contract has been awarded. If needed, LC-MS parameters for detecting Organophosphorous Nerve Agent Metabolites in Urine and

Serum may be provided upon request. CDC will provide ~120 milligrams of each native and labeled analyte mentioned above (GBA, GDA, GFA, rVXA, and VXA) along with the related manufacturer COAs immediately upon award of the contract. CDC will also provide dilution instructions applicable to NAx10-CP and -ISP for inclusion with COAs.

C.7 Place of Performance:

100% of the purchase order will be performed off-site at the contractor’s facilities. No travel is anticipated for this requirement.

C.8 Special Considerations:

HHSAR 352.239-73 Electronic and Information Technology Accessibility Notice (DEC 2015)

(a) Section 508 of the Rehabilitation Act of 1973 (29 U.S.C. 794d), as amended by the Workforce Investment Act of

1998 and the Architectural and Transportation Barriers Compliance Board Electronic and Information (EIT)

Accessibility Standards (36 CFR part 1194), require that when Federal agencies develop, procure, maintain, or use electronic and information technology, Federal employees with disabilities have access to and use of information and data that is comparable to the access and use by Federal employees who are not individuals with disabilities, unless an undue burden would be imposed on the agency. Section 508 also requires that individuals with disabilities, who are members of the public seeking information or services from a Federal agency, have access to and use of information and data that is comparable to that provided to the public who are not individuals with disabilities, unless an undue burden would be imposed on the agency.

(b) Accordingly, any offeror responding to this solicitation must comply with established HHS EIT accessibility standards. Information about Section 508 is available at http://www.hhs.gov/web/508. The complete text of the

Section 508 Final Provisions can be accessed at http://www.access-aboard.gov/sec508/standards.htm.

(c) The Section 508 accessibility standards applicable to this contract are: 1194.

205 WCAG 2.0 Level A & AA Success Criteria

302 Functional Performance Criteria

502 Inoperability with Assistive Technology

504 Authoring Tools

602 Support Documentation

603 Support Services

In order to facilitate the Government's determination whether proposed EIT supplies meet applicable Section 508 accessibility standards, offerors must submit an HHS Section 508 Product Assessment Template, in accordance with its completion instructions. The purpose of the template is to assist HHS acquisition and program officials in determining whether proposed EIT supplies conform to applicable Section 508 accessibility standards. The template allows offerors or developers to self-evaluate their supplies and documentation detail - whether they conform to a specific Section 508 accessibility standard, and any underway remediation efforts addressing conformance issues.

Instructions for preparing the HHS Section 508 Evaluation Template are available under Section 508 policy on the

HHS Web site http://hhs.gov/web/508.

In order to facilitate the Government's determination whether proposed EIT services meet applicable Section 508 accessibility standards, offerors must provide enough information to assist the Government in determining that the

EIT services conform to Section 508 accessibility standards, including any underway remediation efforts addressing conformance issues.

(d) Respondents to this solicitation must identify any exception to Section 508 requirements. If a offeror claims its supplies or services meet applicable Section 508 accessibility standards, and it is later determined by the

Government, i.e., after award of a contract or order, that supplies or services delivered do not conform to the accessibility standards, remediation of the supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its expense.

(e) Electronic content must be accessible to HHS acceptance criteria. Checklist for various formats are available at http://508.hhs.gov/, or from the Section 508 Coordinator listed at https://www.hhs.gov/web/section-508/additional-resources/section-508-contacts/index.html. Materials that are final items for delivery should be accompanied by the appropriate checklist, except upon approval of the Contracting Officer or Representative.

Section D - Clauses

D.1 FAR 52.252-2 Clauses Incorporated by Reference (Feb 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):

https://www.acquisition.gov

(End of clause)

FAR SOURCE TITLE AND DATE

52.204-13 System for Award Management Maintenance (Oct 2018)

52.204-18 Commercial and Government Entity Code Maintenance (Aug 2020)

52.212-4 Contract Terms and Conditions—Commercial Items (Dec 2022)

HHSAR SOURCE

352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015)

352.223-70 Safety and Health (DEC 2015)

352.237-75 Key Personnel (DEC 2015)

D.2 FAR 52.212-5 - Contract Terms and Conditions Required To Implement Statutes or Executive

Orders—Commercial Products and Commercial Services (Mar 2023)

(a) The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract by reference, to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

(1) 52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (Jan 2017)

(section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L.

113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).

(2) 52.204-23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by

Kaspersky Lab and Other Covered Entities (Nov 2021) (Section 1634 of Pub. L. 115-91).

(3) 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or

Equipment. (Nov 2021) (Section 889(a)(1)(A) of Pub. L. 115-232).

(4) 52.209-10, Prohibition on Contracting with Inverted Domestic Corporations (Nov 2015).

(5) 52.232-40, Providing Accelerated Payments to Small Business Subcontractors (Mar 2023) ( 31 U.S.C. 3903 and

10 U.S.C. 3801).

(6) 52.233-3, Protest After Award (Aug 1996) ( 31 U.S.C. 3553).

(7) 52.233-4, Applicable Law for Breach of Contract Claim (Oct 2004) (Public Laws 108-77 and 108-78 ( 19

U.S.C. 3805 note)).

(b) The Contractor shall comply with the FAR clauses in this paragraph (b) that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

[Contracting Officer check as appropriate.] https://www.acquisition.gov/

__ (1) 52.203-6, Restrictions on Subcontractor Sales to the Government (Jun 2020), with Alternate I (Nov 2021) (41

U.S.C. 4704 and 10 U.S.C. 4655).

__ (2) 52.203-13, Contractor Code of Business Ethics and Conduct (Nov 2021) ( 41 U.S.C. 3509)).

__ (3) 52.203-15, Whistleblower Protections under the American Recovery and Reinvestment Act of 2009 (Jun

2010) (Section 1553 of Pub. L. 111-5). (Applies to contracts funded by the American Recovery and Reinvestment

Act of 2009.)

x (4) 52.204-10, Reporting Executive Compensation and First-Tier Subcontract Awards (Jun 2020) (Pub. L. 109-

282) ( 31 U.S.C. 6101 note).

__ (5) [Reserved].

__ (6) 52.204-14, Service Contract Reporting Requirements (Oct 2016) (Pub. L. 111-117, section 743 of Div. C).

__ (7) 52.204-15, Service Contract Reporting Requirements for Indefinite-Delivery Contracts (Oct 2016) (Pub. L.

111-117, section 743 of Div. C).

x (8) 52.209-6, Protecting the Government’s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (Nov 2021) ( 31 U.S.C. 6101 note).

__ (9) 52.209-9, Updates of Publicly Available Information Regarding Responsibility Matters (Oct 2018) ( 41

U.S.C. 2313).

__ (10) [Reserved].

__ (11) 52.219-3, Notice of HUBZone Set-Aside or Sole-Source Award (Oct 2022) ( 15 U.S.C. 657a).

x (12) 52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (Oct 2022) (if the offeror elects to waive the preference, it shall so indicate in its offer) ( 15 U.S.C. 657a).

__ (13) [Reserved]

__ (14) (i) 52.219-6, Notice of Total Small Business Set-Aside (Nov 2020) ( 15 U.S.C. 644).

__ (ii) Alternate I (Mar 2020) of 52.219-6.

__ (15) (i) 52.219-7, Notice of Partial Small Business Set-Aside (Nov 2020) ( 15 U.S.C. 644).

__ (ii) Alternate I (Mar 2020) of 52.219-7.

__ (16) 52.219-8, Utilization of Small Business Concerns (Oct 2022) ( 15 U.S.C. 637(d)(2) and (3)).

__ (17) (i) 52.219-9, Small Business Subcontracting Plan (Oct 2022) ( 15 U.S.C. 637(d)(4)).

__ (ii) Alternate I (Nov 2016) of 52.219-9.

__ (iii) Alternate II (Nov 2016) of 52.219-9.

__ (iv) Alternate III (Jun 2020) of 52.219-9.

__ (v) Alternate IV (Sep 2021) of 52.219-9.

__ (18) (i) 52.219-13, Notice of Set-Aside of Orders (Mar 2020) ( 15 U.S.C. 644(r)).

__ (ii) Alternate I (Mar 2020) of 52.219-13.

__ (19) 52.219-14, Limitations on Subcontracting (Oct 2022) ( 15 U.S.C. 637s).

__ (20) 52.219-16, Liquidated Damages—Subcontracting Plan (Sep 2021) ( 15 U.S.C. 637(d)(4)(F)(i)).

__ (21) 52.219-27, Notice of Service-Disabled Veteran-Owned Small Business Set-Aside (Oct 2022) ( 15 U.S.C.

657f).

x (22) (i) 52.219-28, Post Award Small Business Program Rerepresentation (May 2023)( 15 U.S.C. 632(a)(2)).

__ (ii) Alternate I (Mar 2020) of 52.219-28.

__ (23) 52.219-29, Notice of Set-Aside for, or Sole-Source Award to, Economically Disadvantaged Women-Owned

Small Business Concerns (Oct 2022) ( 15 U.S.C. 637(m)).

__ (24) 52.219-30, Notice of Set-Aside for, or Sole-Source Award to, Women-Owned Small Business Concerns

Eligible Under the Women-Owned Small Business Program (Oct 2022) ( 15 U.S.C. 637(m)).

__ (25) 52.219-32, Orders Issued Directly Under Small Business Reserves (Mar 2020) ( 15 U.S.C. 644(r)).

__ (26) 52.219-33, Nonmanufacturer Rule (Sep 2021) ( 15U.S.C. 637(a)(17)).

x (27) 52.222-3, Convict Labor (Jun 2003) (E.O.11755).

x (28) 52.222-19, Child Labor-Cooperation with Authorities and Remedies (Dec 2022) (E.O.13126).

x (29) 52.222-21, Prohibition of Segregated Facilities (Apr 2015).

x (30) (i) 52.222-26, Equal Opportunity (Sep 2016) (E.O.11246).

__ (ii) Alternate I (Feb 1999) of 52.222-26.

__ (31) (i) 52.222-35, Equal Opportunity for Veterans (Jun 2020) ( 38 U.S.C. 4212).

__ (ii) Alternate I (Jul 2014) of 52.222-35.

x (32) (i) 52.222-36, Equal Opportunity for Workers with Disabilities (Jun 2020) ( 29 U.S.C. 793).

__ (ii) Alternate I (Jul 2014) of 52.222-36.

__ (33) 52.222-37, Employment Reports on Veterans (Jun 2020) ( 38 U.S.C. 4212).

__ (34) 52.222-40, Notification of Employee Rights Under the National Labor Relations Act (Dec 2010) (E.O.

13496).

x (35) (i) 52.222-50, Combating Trafficking in Persons (Nov 2021) ( 22 U.S.C. chapter 78 and E.O. 13627).

__ (ii) Alternate I (Mar 2015) of 52.222-50 ( 22 U.S.C. chapter 78 and E.O. 13627).

__ (36) 52.222-54, Employment Eligibility Verification (May 2022) (Executive Order 12989). (Not applicable to the acquisition of commercially available off-the-shelf items or certain other types of commercial products or commercial services as prescribed in FAR 22.1803.)

__ (37) (i) 52.223-9, Estimate of Percentage of Recovered Material Content for EPA–Designated Items (May 2008)

( 42 U.S.C. 6962(c)(3)(A)(ii)). (Not applicable to the acquisition of commercially available off-the-shelf items.)

__ (ii) Alternate I (May 2008) of 52.223-9 ( 42 U.S.C. 6962(i)(2)(C)). (Not applicable to the acquisition of commercially available off-the-shelf items.)

__ (38) 52.223-11, Ozone-Depleting Substances and High Global Warming Potential Hydrofluorocarbons (Jun

2016) (E.O. 13693).

__ (39) 52.223-12, Maintenance, Service, Repair, or Disposal of Refrigeration Equipment and Air Conditioners (Jun

2016) (E.O. 13693).

__ (40) (i) 52.223-13, Acquisition of EPEAT®-Registered Imaging Equipment (Jun 2014) (E.O.s 13423 and 13514).

__ (ii) Alternate I (Oct 2015) of 52.223-13.

__ (41) (i) 52.223-14, Acquisition of EPEAT®-Registered Televisions (Jun 2014) (E.O.s 13423 and 13514).

__ (ii) Alternate I (Jun2014) of 52.223-14.

__ (42) 52.223-15, Energy Efficiency in Energy-Consuming Products (May 2020) ( 42 U.S.C. 8259b).

__ (43) (i) 52.223-16, Acquisition of EPEAT®-Registered Personal Computer Products (Oct 2015) (E.O.s 13423 and 13514).

__ (ii) Alternate I (Jun 2014) of 52.223-16.

x (44) 52.223-18, Encouraging Contractor Policies to Ban Text Messaging While Driving (Jun 2020) (E.O. 13513).

__ (45) 52.223-20, Aerosols (Jun 2016) (E.O. 13693).

__ (46) 52.223-21, Foams (Jun2016) (E.O. 13693).

__ (47) (i) 52.224-3 Privacy Training (Jan 2017) (5 U.S.C. 552 a).

__ (ii) Alternate I (Jan 2017) of 52.224-3.

x (48) (i) 52.225-1, Buy American-Supplies (Oct 2022) ( 41 U.S.C. chapter 83).

__ (ii) Alternate I (Oct 2022) of 52.225-1.

__ (49) (i) 52.225-3, Buy American-Free Trade Agreements-Israeli Trade Act (Dec 2022) ( 19 U.S.C. 3301 note, 19

U.S.C. 2112 note, 19 U.S.C. 3805 note, 19 U.S.C. 4001 note, 19 U.S.C. chapter 29 (sections 4501-4732), Public

Law 103-182, 108-77, 108-78, 108-286, 108-302, 109-53, 109-169, 109-283, 110-138, 112-41, 112-42, and 112-43.

__ (ii) Alternate I [Reserved].

__ (iii) Alternate II (Dec 2022) of 52.225-3.

__ (iv) Alternate III (Jan 2021) of 52.225-3.

__ (v) Alternate IV (Oct 2022) of 52.225-3.

__ (50) 52.225-5, Trade Agreements (Dec 2022) ( 19 U.S.C. 2501, et seq., 19 U.S.C. 3301 note).

x (51) 52.225-13, Restrictions on Certain Foreign Purchases (Feb 2021) (E.O.’s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury).

__ (52) 52.225-26, Contractors Performing Private Security Functions Outside the United States (Oct 2016) (Section

862, as amended, of the National Defense Authorization Act for Fiscal Year 2008; 10 U.S.C. Subtitle A, Part V, Subpart G Note).

__ (53) 52.226-4, Notice of Disaster or Emergency Area Set-Aside (Nov 2007) ( 42 U.S.C. 5150).

__ (54) 52.226-5, Restrictions on Subcontracting Outside Disaster or Emergency Area (Nov2007) ( 42 U.S.C. 5150).

__ (55) 52.229-12, Tax on Certain Foreign Procurements (Feb 2021).

__ (56) 52.232-29, Terms for Financing of Purchases of Commercial Products and Commercial Services (Nov 2021)

( 41 U.S.C. 4505, 10 U.S.C. 3805).

__ (57) 52.232-30, Installment Payments for Commercial Products and Commercial Services (Nov 2021) ( 41

U.S.C. 4505, 10 U.S.C. 3805).

x (58) 52.232-33, Payment by Electronic Funds Transfer-System for Award Management (Oct 2018) ( 31 U.S.C.

3332).

__ (59) 52.232-34, Payment by Electronic Funds Transfer-Other than System for Award Management (Jul 2013) (

31 U.S.C. 3332).

__ (60) 52.232-36, Payment by Third Party (May 2014) ( 31 U.S.C. 3332).

__ (61) 52.239-1, Privacy or Security Safeguards (Aug 1996) ( 5 U.S.C. 552a).

__ (62) 52.242-5, Payments to Small Business Subcontractors (Jan 2017) ( 15 U.S.C. 637(d)(13)).

__ (63) (i) 52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels (Nov 2021) ( 46 U.S.C. 55305 and 10 U.S.C. 2631).

__ (ii) Alternate I (Apr 2003) of 52.247-64.

__ (iii) Alternate II (Nov 2021) of 52.247-64.

(c) The Contractor shall comply with the FAR clauses in this paragraph (c), applicable to commercial services, that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

[Contracting Officer check as appropriate.] x (1) 52.222-41, Service Contract Labor Standards (Aug 2018) ( 41 U.S.C. chapter67).

X (2) 52.222-42, Statement of Equivalent Rates for Federal Hires (May 2014) ( 29 U.S.C. 206 and 41 U.S.C.

chapter 67).

__ (3) 52.222-43, Fair Labor Standards Act and Service Contract Labor Standards-Price Adjustment (Multiple Year and Option Contracts) (Aug 2018) ( 29 U.S.C. 206 and 41 U.S.C. chapter 67).

__ (4) 52.222-44, Fair Labor Standards Act and Service Contract Labor Standards-Price Adjustment (May 2014) (

29U.S.C.206 and 41 U.S.C. chapter 67).

__ (5) 52.222-51, Exemption from Application of the Service Contract Labor Standards to Contracts for

Maintenance, Calibration, or Repair of Certain Equipment-Requirements (May 2014) ( 41 U.S.C. chapter 67).

__ (6) 52.222-53, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain

Services-Requirements (May 2014) ( 41 U.S.C. chapter 67).

x (7) 52.222-55, Minimum Wages for Contractor Workers Under Executive Order 14026 (Jan 2022).

x (8) 52.222-62, Paid Sick Leave Under Executive Order 13706 (Jan 2022) (E.O. 13706).

__ (9) 52.226-6, Promoting Excess Food Donation to Nonprofit Organizations (Jun 2020) ( 42 U.S.C. 1792).

(d) Comptroller General Examination of Record. The Contractor shall comply with the provisions of this paragraph

(d) if this contract was awarded using other than sealed bid, is in excess of the simplified acquisition threshold, as defined in FAR 2.101, on the date of award of this contract, and does not contain the clause at 52.215-2, Audit and

Records-Negotiation.

(1) The Comptroller General of the United States, or an authorized representative of the Comptroller General, shall have access to and right to examine any of the Contractor’s directly pertinent records involving transactions related to this contract.

(2) The Contractor shall make available at its offices at all reasonable times the records, materials, and other evidence for examination, audit, or reproduction, until 3 years after final payment under this contract or for any shorter period specified in FAR subpart 4.7, Contractor Records Retention, of the other clauses of this contract. If this contract is completely or partially terminated, the records relating to the work terminated shall be made available for 3 years after any resulting final termination settlement. Records relating to appeals under the disputes clause or to litigation or the settlement of claims arising under or relating to this contract shall be made available until such appeals, litigation, or claims are finally resolved.

(3) As used in this clause, records include books, documents, accounting procedures and practices, and other data, regardless of type and regardless of form. This does not require the Contractor to create or maintain any record that the Contractor does not maintain in the ordinary course of business or pursuant to a provision of law.

(e) (1) Notwithstanding the requirements of the clauses in paragraphs (a), (b), (c), and (d) of this clause, the

Contractor is not required to flow down any FAR clause, other than those in this paragraph (e)(1), in a subcontract for commercial products or commercial services. Unless otherwise indicated below, the extent of the flow down shall be as required by the clause-

(i) 52.203-13, Contractor Code of Business Ethics and Conduct (Nov 2021) ( 41 U.S.C. 3509).

(ii) 52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (Jan 2017)

(section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L.

113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).

(iii) 52.204-23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by

Kaspersky Lab and Other Covered Entities (Nov 2021) (Section 1634 of Pub. L. 115-91).

(iv) 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or

Equipment. (Nov 2021) (Section 889(a)(1)(A) of Pub. L. 115-232).

(v) 52.219-8, Utilization of Small Business Concerns (Oct 2022) ( 15 U.S.C. 637(d)(2) and (3)), in all subcontracts that offer further subcontracting opportunities. If the subcontract (except subcontracts to small business concerns) exceeds the applicable threshold specified in FAR 19.702(a) on the date of subcontract award, the subcontractor must include 52.219-8 in lower tier subcontracts that offer subcontracting opportunities.

(vi) 52.222-21, Prohibition of Segregated Facilities (Apr 2015).

(vii) 52.222-26, Equal Opportunity (Sep 2015) (E.O.11246).

(viii) 52.222-35, Equal Opportunity for Veterans (Jun 2020) ( 38 U.S.C. 4212).

(ix) 52.222-36, Equal Opportunity for Workers with Disabilities (Jun 2020) ( 29 U.S.C. 793).

(x) 52.222-37, Employment Reports on Veterans (Jun 2020) ( 38 U.S.C. 4212).

(xi) 52.222-40, Notification of Employee Rights Under the National Labor Relations Act (Dec 2010) (E.O. 13496).

Flow down required in accordance with paragraph (f) of FAR clause 52.222-40.

(xii) 52.222-41, Service Contract Labor Standards (Aug 2018) ( 41 U.S.C. chapter 67).

(xiii) (A) 52.222-50, Combating Trafficking in Persons (Nov 2021) ( 22 U.S.C. chapter 78 and E.O 13627).

(B) Alternate I (Mar 2015) of 52.222-50 ( 22 U.S.C. chapter 78 and E.O. 13627).

(xiv) 52.222-51, Exemption from Application of the Service Contract Labor Standards to Contracts for

Maintenance, Calibration, or Repair of Certain Equipment-Requirements (May 2014) ( 41 U.S.C. chapter 67).

(xv) 52.222-53, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain

Services-Requirements (May 2014) ( 41 U.S.C. chapter 67).

(xvi) 52.222-54, Employment Eligibility Verification (May 2022) (E.O. 12989).

(xvii) 52.222-55, Minimum Wages for Contractor Workers Under Executive Order 14026 (Jan 2022).

(xviii) 52.222-62, Paid Sick Leave Under Executive Order 13706 (Jan 2022) (E.O. 13706).

(xix) (A) 52.224-3, Privacy Training (Jan 2017) ( 5 U.S.C. 552a).

(B) Alternate I (Jan 2017) of 52.224-3.

(xx) 52.225-26, Contractors Performing Private Security Functions Outside the United States (Oct 2016) (Section

862, as amended, of the National Defense Authorization Act for Fiscal Year 2008; 10 U.S.C. Subtitle A, Part V, Subpart G Note).

(xxi) 52.226-6, Promoting Excess Food Donation to Nonprofit Organizations (Jun 2020) ( 42 U.S.C. 1792). Flow down required in accordance with paragraph (e) of FAR clause 52.226-6.

(xxii) 52.232-40, Providing Accelerated Payments to Small Business Subcontractors (Mar 2023) ( 31 U.S.C. 3903 and 10 U.S.C. 3801). Flow down required in accordance with paragraph (c) of 52.232-40.

(xxiii) 52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels (Nov 2021) ( 46 U.S.C. 55305 and 10 U.S.C. 2631). Flow down required in accordance with paragraph (d) of FAR clause 52.247-64.

(2) While not required, the Contractor may include in its subcontracts for commercial products and commercial services a minimal number of additional clauses necessary to satisfy its contractual obligations.

D.3 FAR 52.222-49 Service Contract Labor Standards – Place of Performance Unknown (May 2014)

(a) This contract is subject to the Service Contract Labor Standards statute, and the place of performance was unknown when the solicitation was issued. In addition to places or areas identified in wage determinations, if any, attached to the solicitation, wage determinations have also been requested for the following: none. The Contracting

Officer will request wage determinations for additional places or areas of performance if asked to do so in writing by

May 14, 2023 at 5:00 PM EDT.

(b) Offerors who intend to perform in a place or area of performance for which a wage determination has not been attached or requested may nevertheless submit bids or proposals. However, a wage determination shall be requested and incorporated in the resultant contract retroactive to the date of contract award, and there shall be no adjustment in the contract price.

D.4 HHSAR 352.232-71 Electronic Submission of Payment Requests (FEB 2022)

(a) Definitions. As used in this clause—

(1) Payment request means a bill, voucher, invoice, or request for contract financing payment with associated supporting documentation. The payment request must comply with the requirements identified in FAR 32.905(b), “Content of Invoices” and the applicable Payment clause included in this contract.

(b) Except as provided in paragraph (c) of this clause, the Contractor shall submit payment requests electronically using the Department of Treasury Invoice Processing Platform (IPP) or successor system. Information regarding

IPP, including IPP Customer Support contact information, is available at www.ipp.gov or any successor site.

(c) The Contractor may submit payment requests using other than IPP only when the Contracting Officer authorizes alternate procedures in writing in accordance with HHS procedures.

(d) If alternate payment procedures are authorized, the Contractor shall include a copy of the Contracting Officer's written authorization with each payment request.

(End of Clause)

D.5 HHSAR 352.239-74 Electronic and Information Technology Accessibility (DEC 2015)

(a) Pursuant to Section 508 of the Rehabilitation Act of 1973 (29 U.S.C. 794d), as amended by the Workforce

Investment Act of 1998, all electronic and information technology (EIT) supplies and services developed, acquired, or maintained under this contract or order must comply with the “Architectural and Transportation Barriers

Compliance Board Electronic and Information Technology (EIT) Accessibility Standards” set forth by the

Architectural and Transportation Barriers Compliance Board (also referred to as the “Access Board”) in 36 CFR part

1194. Information about Section 508 is available at http://www.hhs.gov/web/508. The complete text of Section 508

Final Provisions can be accessed at http://www.access-board.gov/guidelines-and-standards/communications-and-it/about-the-section-508-standards.

(b) The Section 508 accessibility standards applicable to this contract or order are identified in the Statement of

Work or Specification or Performance Work Statement. The contractor must provide any necessary updates to the submitted HHS Product Assessment Template(s) at the end of each contract or order exceeding the simplified acquisition threshold (see FAR 2.101) when the contract or order duration is one year or less. If it is determined by https://www.ipp.gov/ the Government that EIT supplies and services provided by the Contractor do not conform to the described accessibility standards in the contract, remediation of the supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its own expense.

(c) The Section 508 accessibility standards applicable to this contract are: 1194.

205 WCAG 2.0 Level A & AA Success Criteria

302 Functional Performance Criteria

502 Inoperability with Assistive Technology

504 Authoring Tools

602 Support Documentation

603 Support Services

(d) In the event of a modification(s) to this contract or order, which adds new EIT supplies or services or revises the type of, or specifications for, supplies or services, the Contracting Officer may require that the contractor submit a completed HHS Section 508 Product Assessment Template and any other additional information necessary to assist the Government in determining that the EIT supplies or services conform to Section 508 accessibility standards.

Instructions for documenting accessibility via the HHS Section 508 Product Assessment Template may be found under Section 508 policy on the HHS Web site: (http://www.hhs.gov/web/508). If it is determined by the

Government that EIT supplies and services provided by the Contractor do not conform to the described accessibility standards in the contract, remediation of the supplies or services to the level of conformance specified in the contract will be the responsibility of the Contractor at its own expense.

(e) If this is an Indefinite Delivery contract, a Blanket Purchase Agreement or a Basic Ordering Agreement, the task/delivery order requests that include EIT supplies or services…